Collin Kim
Net worth: 19 929 $ as of 30/07/2026
Net worth: 19 929 $ as of 30/07/2026
Sang Goo Kim is currently Director at Biocure Technology, Inc. since 2015 and Vice President at Columbia Capital, Inc. since 2008.
Former positions include Independent Director at Gravis Energy Corp.
and Independent Director at First Atlantic Nickel & Cobalt Corp.
from 2015 to 2020.
Education includes an undergraduate degree from Korea University, conferred in 1990.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/07/2025 | 1,992,877 ( 9.86% ) | 19 929 $ | 30/07/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOCURE TECHNOLOGY INC. | Director/Board Member | 27/08/2015 |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Corporate Officer/Principal | 31/12/2007 |
| Companies | Position | End |
|---|---|---|
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Director/Board Member | - |
| FIRST ATLANTIC NICKEL & COBALT CORP. | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
First Atlantic Nickel Corp.
First Atlantic Nickel Corp. Other Metals/MineralsNon-Energy Minerals Engages in the acquisition, evaluation, exploration, and development of oil, gas, and mineral resources | Non-Energy Minerals |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Non-Energy Minerals |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Finance |
Biocure Technology, Inc.
Biocure Technology, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions